ArmaGen Technologies
Santa Monica
About ArmaGen Technologies
ArmaGen is a developer of therapies designed to address neurological complications. The company's pipeline of innovative therapies penetrate the blood-brain barrier to treat neurological complications of many diseases, including lysosomal storage disorders (LSDs), Alzheimer's and Parkinson's, enabling patients suffering from neurodegenerative disorders to get improved treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.5M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2018)
- Website: armagen.com
- Phone: 8182528214
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/armagen-technologies-64718 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.